Research institute

Mexican Architect Tatiana Bilbao to Receive Honorary Doctorate At Boston Architectural College's 2024 Commencement

Retrieved on: 
星期二, 五月 7, 2024
Olive, Advisory Council, Sea, Honorary title (academic), University, City, This Old House, Yale School of Architecture, Housing, GSAPP, Columbia University, Research, House, UDEM, The New York Times, Development, Sustainable architecture, Domus, Culture, RAIC, Research institute, Ministry, Human voice, Empathy, Federal district, Boston Architectural College, Harvard University, Rice University, Government

BOSTON, May 7, 2024 /PRNewswire/ -- The Boston Architectural College (BAC) is delighted to announce that renowned Mexican architect Tatiana Bilbao will be this year's commencement speaker and recipient of an honorary doctorate.

Key Points: 
  • BOSTON, May 7, 2024 /PRNewswire/ -- The Boston Architectural College (BAC) is delighted to announce that renowned Mexican architect Tatiana Bilbao will be this year's commencement speaker and recipient of an honorary doctorate.
  • "As the BAC continues to honor design visionaries, we are thrilled to recognize acclaimed architect Tatiana Bilbao as our commencement speaker and an honorary doctorate recipient for professional excellence," said President Mahesh Daas.
  • Based in Mexico City, Tatiana Bilbao began her studio, Tatiana Bilbao ESTUDIO, in 2004 with the aim of research, design, community-led strategies, and responsible construction.
  • "Receiving such a distinction [from The Boston Architectural College] is both an honor and a responsibility, to both I am truly thankful," said Tatiana Bilbao.

BeyondSpring To Host Virtual R&D Day to Discuss New Plinabulin Development Strategy for Cancer and Updates for SEED Therapeutics

Retrieved on: 
星期五, 五月 3, 2024
University, Research and development, Radiation, Oncology, Research, Abstract, Immunotherapy, MD, University School, Cayetano Heredia University, Internet, Lung cancer, Radiation therapy, Johns Hopkins Hospital, International Association, Respiratory disease, Society, Lung, MD Anderson Cancer Center, Publication, Biomarker, Research institute, Esophageal cancer, Therapy, Cancer

The conference call and webinar will feature presentations by Key Opinion Leaders (KOLs) Trevor M. Feinstein, M.D.

Key Points: 
  • The conference call and webinar will feature presentations by Key Opinion Leaders (KOLs) Trevor M. Feinstein, M.D.
  • (MD Anderson Cancer Center), who will discuss below topics:
    Also featured will be a management discussion on technology platform and pipeline updates of SEED Therapeutics, BeyondSpring’s majority-owned molecular glue subsidiary.
  • He joined Piedmont Cancer Institute in 2011 and is the Director of Research at Piedmont Fayette Hospital.
  • Dr. Lin runs a translational research team that evaluates biomarkers for treatment response and disease outcomes after cancer therapy.

KARL STORZ and Well Lead Medical Announce Exclusive Agreement for Distribution of ClearPetra Stone-Removal System in the U.S.

Retrieved on: 
星期四, 五月 2, 2024
Health Technology, Health, Medical Devices, Well, MIT Tech Talk, Urology, Kidney, American Urological Association, Marketing, Cleveland Clinic, MD, PCNL, Gynaecology, FRCSC, Stone, Booth, Master of Science, AUA, KARL, Research institute, Pharmaceutical industry

KARL STORZ United States announces an exclusive agreement with Well Lead Medical to offer the ClearPetra suction-evacuation ureteral access sheath in conjunction with KARL STORZ endoscopic visualization devices for comprehensive urinary stone management.

Key Points: 
  • KARL STORZ United States announces an exclusive agreement with Well Lead Medical to offer the ClearPetra suction-evacuation ureteral access sheath in conjunction with KARL STORZ endoscopic visualization devices for comprehensive urinary stone management.
  • “Our strategic collaboration with Well Lead Medical on ClearPetra represents a major step forward in stone management.
  • “The collaboration between Well Lead Medical and KARL STORZ represents a significant milestone in our commitment to advancing endourology.
  • During the show, KARL STORZ will be sponsoring a Tech Talk on May 4, 10:00–10:25 a.m., at Booth #1733.

Prota Therapeutics' CEO Mimi Tang honoured at BioMelbourne Network's Women in Leadership Awards 2024

Retrieved on: 
星期一, 四月 29, 2024
Society, Murdoch Children's Research Institute, Health, Food allergy, MCRI, Parent, American Biographical Institute, Food, Patient, Anaphylaxis, Allergy, Research institute, Therapy, Peanut allergy, Woman, Pharmaceutical industry

MELBOURNE, Australia, April 29, 2024 /PRNewswire/ -- Prota Therapeutics' CEO Professor Mimi Tang has been honoured in the prestigious 2024 BioMelbourne Network Women in Leadership Awards.

Key Points: 
  • MELBOURNE, Australia, April 29, 2024 /PRNewswire/ -- Prota Therapeutics' CEO Professor Mimi Tang has been honoured in the prestigious 2024 BioMelbourne Network Women in Leadership Awards.
  • As the CEO of Prota Therapeutics, Professor Tang has demonstrated remarkable vision and resilience in advancing the company's mission to provide transformative treatments for food allergies.
  • "Receiving the 2024 Distinguished Leadership Award from the BioMelbourne Network is a tremendous honour.
  • The BioMelbourne Network Women in Leadership Awards celebrate individuals who demonstrate exceptional leadership qualities, contribute significantly to the health industry, and inspire positive change within the community.

Emtora Clinical Data to be Highlighted in Podium Presentation at Prestigious 2024 Digestive Disease Week Annual Meeting

Retrieved on: 
星期二, 四月 30, 2024
Research, Other Health, General Health, Pharmaceutical, Oncology, Infectious Diseases, Hospitals, Genetics, Surgery, Clinical Trials, Science, Biotechnology, Health, REDUCE, Cancer prevention, Gastroenterology, Safety, MD, FAP, Polyp, Gastrointestinal tract, Patient, Physician, Endoscopy, DDW, Research institute, Quality of life, Pharmaceutical industry

Emtora Biosciences, Inc., a privately-held, San Antonio-based biotechnology company developing a novel reformulated version of a previously-approved drug today announced the acceptance of an abstract for oral presentation at the upcoming Digestive Disease Week (“DDW”) Annual Meeting.

Key Points: 
  • Emtora Biosciences, Inc., a privately-held, San Antonio-based biotechnology company developing a novel reformulated version of a previously-approved drug today announced the acceptance of an abstract for oral presentation at the upcoming Digestive Disease Week (“DDW”) Annual Meeting.
  • DDW is the world’s premier meeting for physicians, researchers, and industry in the fields of gastroenterology, hepatology, endoscopy, and gastrointestinal surgery, which will take place in Washington D.C. May 18-21, 2024.
  • FAP is an incurable systemic disease for which no approved chemo-preventive agent exists.
  • Presentation: PHASE IIA TRIAL OF ENCAPSULATED RAPAMYCIN (ERAPA) IN PATIENTS WITH FAMILIAL ADENOMATOUS POLYPOSIS TO REDUCE INTESTINAL POLYP BURDEN: 6 MONTH INTERIM RESULTS

Phoenix Children's Names New Chief of Neurosurgery

Retrieved on: 
星期三, 四月 24, 2024
UCLA, Health system, Lead, University, Mayo Clinic, Bangladesh Technical Education Board, Hospital, Neuropsychology, General surgery, News, Neuroscience, MD, Doctor of Philosophy, Research, New Jersey Medical School, Barrow Neurological Institute, Spine, Editorial, Neurology, Neurosurgery, Child, Epilepsy, Neoplasm, Seattle Children's, Rehabilitation, Research institute, Growth, Nursing

PHOENIX, April 24, 2024 /PRNewswire/ -- Phoenix Children's, one of the nation's fastest-growing pediatric health systems, today announced the hire of accomplished surgeon-scientist Jason Scott Hauptman, MD, PhD, as division chief of neurosurgery, part of Barrow Neurological Institute at Phoenix Children's. His appointment is part of a broader effort to hire top clinical and research leadership in high-demand specialty areas as Phoenix Children's solidifies its position as the premier pediatric health system in the Southwest.

Key Points: 
  • "Patient families will benefit from Dr. Hauptman's epilepsy surgery expertise, and our health system will benefit from his impressive track record in medical education, mentorship, research and academia," said Daniel Ostlie, MD, surgeon in chief at Phoenix Children's.
  • As division chief of neurosurgery at Phoenix Children's , Dr. Hauptman will provide strategic direction and administrative leadership while also collaborating with multidisciplinary teams to provide top-quality clinical care for children with neurological conditions.
  • He will also hold academic appointments with Mayo Clinic Arizona, Creighton University School of Medicine and the University of Arizona College of Medicine — Phoenix.
  • Phoenix Children's is consistently recognized as one of U.S. News & World Report's " Best Children's Hospitals " for neurology and neurosurgery.

BCG Announces Collaborations with NASA and USRA to Launch a Generative Artificial Intelligence Lab for Science and Engineering

Retrieved on: 
星期四, 四月 18, 2024
USRA, Geostationary Operational Environmental Satellite, Earth science, Weather, AI, Research, NASA, Artificial intelligence, Ames Research Center, BCG, Universities Space Research Association, Intelligence, Engineering, Science, Silicon, GOES, Boston Consulting Group, Research institute, Government, Growth

SILICON VALLEY, Calif. and WASHINGTON, April 18, 2024 /PRNewswire/ -- Boston Consulting Group (BCG) today announced strategic collaborations with NASA's Ames Research Center in California's Silicon Valley and the Universities Space Research Association (USRA) to launch a generative artificial intelligence (GenAI) lab for science and engineering.

Key Points: 
  • SILICON VALLEY, Calif. and WASHINGTON, April 18, 2024 /PRNewswire/ -- Boston Consulting Group (BCG) today announced strategic collaborations with NASA's Ames Research Center in California's Silicon Valley and the Universities Space Research Association (USRA) to launch a generative artificial intelligence (GenAI) lab for science and engineering.
  • The lab will explore the short- and long-term benefits of new GenAI technologies related to Earth science, including Geostationary Operational Environmental Satellite (GOES) weather data, life sciences, and engineering.
  • These collaborations harness the talents of a unique team of leading innovators from industry (BCG), government (NASA), and academia (USRA) with decades of experience advancing the state-of-the-art in artificial intelligence.
  • "We have only just begun to explore the transformative power of GenAI in Earth sciences," said Christoph Schweizer, CEO of BCG.

New Study Finds Continuing Pervasive Disparities in Access to In-Network Mental Health and Substance Use Disorder Treatment

Retrieved on: 
星期三, 四月 17, 2024
Parity, American Psychiatric Association, National Alliance, Research, Quality, RTI International, National Association, Patient, Mental health, Physician, Milliman, American Psychological Association, Research institute, HRSA, RTI, Health insurance

RESEARCH TRIANGLE PARK, N.C., April 17, 2024 /PRNewswire/ -- A new study by health economists at nonprofit research institute RTI International adds to recent research demonstrating a lack of access to affordable mental health and substance use disorder treatment in the U.S.

Key Points: 
  • Notably, physician assistants were reimbursed for office visits at an average amount 19% higher than psychiatrists and 23% higher than psychologists.
  • "Our findings echo recent surveys and secret shopper studies that show much greater dissatisfaction with, and lower access to, behavioral health providers than medical/surgical providers."
  • "RTI concluded that high out-of-network use for mental health and substance use treatment cannot be explained by a shortage of behavioral health providers," said Henry Harbin, M.D., senior advisor to The Bowman Family Foundation.
  • The report was commissioned by the Mental Health Treatment and Research Institute, a tax-exempt subsidiary of The Bowman Family Foundation.

The Song of the Earth: Artistic Documentary for a Better China Exhibition by CAA held in Beijing

Retrieved on: 
星期三, 四月 17, 2024
Local government, Digital technology, Education, Agriculture, Exhibition, School, Research, Biophysical environment, CAA, Tourism, Culture, Ministry, Environment, Song, Multimedia, Natural Resources, Civilization, Research institute, Government, Philosophy, China Millennium Monument

BEIJING, April 16, 2024 /PRNewswire/ -- The Song of the Earth: Artistic Documentary for a Better China exhibition opened on March 20 at China Millennium Monument's Beijing World Art Museum.

Key Points: 
  • BEIJING, April 16, 2024 /PRNewswire/ -- The Song of the Earth: Artistic Documentary for a Better China exhibition opened on March 20 at China Millennium Monument's Beijing World Art Museum.
  • This exhibition presents typical stories of two complementary threads to interpret the concept of a "Better China".
  • The Song of the Earth: Artistic Documentary for a Better China exhibition takes "experiencing China's geography" as its gist.
  • While appreciating society-wide innovative efforts to create a Better China, they can embark on a magnificent tour of a Better China.

New Findings in JNCCN Illustrate Pathway for Screening High-Risk Individuals for Pancreatic Cancer in PRECEDE Study

Retrieved on: 
星期二, 四月 16, 2024
University, Clinical trial, NCCN, Pancreas, McGill University Health Centre, Risk, Pancreatic cancer, Breast, Prevalence, Cancer, National Comprehensive Cancer Network, Rosalind, Survival, Survival rate, Cyst, Doctor of Philosophy, Huntsman Cancer Institute, Research, Moores Cancer Center, Consortium, Disease, Incidence, Patient, Pancreatic Cancer Action Network, Diagnosis, Research institute, PGV, Dana–Farber Cancer Institute, Morávek, UC, McGill University, Pharmaceutical industry

PLYMOUTH MEETING, Pa., April 16, 2024 /PRNewswire/ -- New research in the April 2024 issue of JNCCN—Journal of the National Comprehensive Cancer Network showcases the feasibility of improving early detection and prevention for pancreatic cancer. Global incidences of pancreatic cancer have risen dramatically in recent years, but the overall survival rate is currently only 12%. When pancreatic neoplasms are detected early enough for treatment with surgical resection, the survival rate climbs to better than 80%, but unfortunately the vast majority of patients are diagnosed with advanced-stage disease. The Pancreatic Cancer Early Detection (PRECEDE) Consortium is a global effort to increase screening capacity for this disease. Of 1,759 participants sorted into the highest-risk cohort, nearly 80% completed baseline imaging through PRECEDE.

Key Points: 
  • Global incidences of pancreatic cancer have risen dramatically in recent years, but the overall survival rate is currently only 12%.
  • The Pancreatic Cancer Early Detection (PRECEDE) Consortium is a global effort to increase screening capacity for this disease.
  • "I look forward to further research... to improve access to pancreatic cancer screening for high-risk individuals."
  • "Longer follow-up time is needed to determine if familial pancreatic cancer signifies a higher risk for developing pancreatic cancer compared to pathogenic germline variant (PGV) status in a pancreatic cancer predisposition gene."